Fluicell AB
Research Fluicell AB (FLUI) on Bullrun: market cap SEK 38.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFLUI
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 38.74M
- Financial periodQ4 2025
- RevenueSEK 3.84M
- Net incomeSEK 101.00K
- Free cash flowSEK 1.27M
- Gross margin132.0%
Valuation Snapshot
latest market cap is SEK 38.74M.
About Fluicell AB
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds;
Frequently asked questions
What is Fluicell AB's market cap?
Fluicell AB's market capitalization is SEK 38.74M.
What does Fluicell AB do?
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics;